Cargando…
Clinical assessment of levamlodipine besylate combination therapy for essential hypertension: A protocol for systematic review and meta-analysis
BACKGROUND: Essential hypertension has been regarded a significant risk factor for cardiovascular disease across the globe, and a significant escapable causation of early death as well as morbidity in the U.S. When angiotensin II receptor blockers and calcium channel blockers are used to treat essen...
Autores principales: | Dai, Guo-Yao, Zhu, Ye-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276456/ https://www.ncbi.nlm.nih.gov/pubmed/35421067 http://dx.doi.org/10.1097/MD.0000000000029148 |
Ejemplares similares
-
Effect of low-dose Levamlodipine Besylate in the treatment of vascular dementia
por: Yao, Kai-Xin, et al.
Publicado: (2019) -
Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study
por: Li, Xin, et al.
Publicado: (2020) -
Clinical assessment of synbiotics for treating chronic kidney disease: A protocol for systematic review and meta-analysis
por: Li, Xiao-Jun, et al.
Publicado: (2020) -
The effectiveness of cyclosporine A for patients with steroid-resistant nephrotic syndrome: A protocol for systematic review and meta-analysis
por: Lv, Juan, et al.
Publicado: (2021) -
Aerobic, resistance and combined training for adults with chronic kidney disease: A protocol for a systematic review and network meta-analysis
por: Zeng, Rong, et al.
Publicado: (2020)